Pseudomonas aeruginosa is an opportunistic pathogen causing septicemia and severe, often lethal, infections of the respiratory tract, urinary tract, burn wounds, and blood (11) . In patients with cystic fibrosis (CF), P. aeruginosa causes chronic pulmonary infections which remain intractable to antibiotic therapy, making this pathogen the major cause of morbidity and mortality in these patients (57) .
The chronic nature and persistence of these bacteria in the CF lung depend in large part on the elaboration of a viscous mucoid exopolysaccharide coat, called alginate (40) . Al- though mucoid strains of P. aeruginosa are rarely found in other clinical situations, their presence in CF patients is highly predictable, suggesting that the CF-affected lung provides a unique environment for inducing alginate production. Secretion of alginate also appears to provide survival advantages to the bacteria, such as by decreasing the uptake and early bactericidal effect of aminoglycosides (3) and inhibiting nonopsonic phagocytosis by monocytes and neutrophils both in vitro (3, 21) and in vivo (2) . Once mucoid P. aeruginosa cells colonize the CF lung, all efforts to eradicate the bacteria, including aggressive antibiotic therapy and physiotherapy, have proven unsuccessful (57) .
P. aeruginosa alginate is composed of a linear polymer of 0-1-4-linked D-mannuronic and L-guluronic acids which is variably modified with O-acetyl groups on the mannuronic acid residues (27) . Much of the pathway of alginate biosynthesis in P. aeruginosa has been defined, on the basis of fructose-6-phosphate as the initial precursor molecule (see references 40 and 45 for reviews). Many of the enzymes involved in alginate biosynthesis are clustered on about 18 kb of DNA near argF at 35 min on the P. aeruginosa chromosomal map (13) (Fig. 1 ) and appear to form an operon (9) . These include algA, encoding the bifunctional enzyme 
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains, phages, and plasmids used in this study are shown in Table 1 . P. aeruginosa FRD strains 1120, 1128, 1131, 1136, and 1145 containing characterized TnSOJ insertions in the alginate biosynthetic gene cluster were described by Chitnis and Ohman (9) . Broad-host-range plasmids with defined TnSOl insertions within the alginate gene cluster (pCC27::TnSOl-14 and pCC27::TnSOJ-26) have been described previously (8) and were mobilized into P. aeruginosa FRD1 as described below.
DNA manipulations. Most routine genetic manipulations and plasmid extractions were done as described by Sambrook et al. (49) . Plasmids used and constructed are shown in Table 1 . Plasmids were mutagenized by TnS01 insertions with plasmid RSF1010::TnS5O as the transposon donor with protocols previously described (47) . The sites of TnS01 insertions were mapped by restriction fragment analysis. P. aeruginosa FRD1150 was constructed by gene replacement as previously described (47) . Triparental matings were used to mobilize recombinant plasmids from E. coli to P. aeruginosa PA01 with the conjugative helper plasmid pRK2013 by methods detailed elsewhere (28) and transferred to strain FRD1 with phage F116L transduction and gene recombination methods (47) . A chloramphenicol acetyltransferase (CAT) polylinker cassette was constructed to permit ready insertion into several different unique restriction enzyme sites within genes of interest. The ca. 2.9-kb BamHI-HindIII fragment from pRU686 containing the CAT gene (58) was blunted with Klenow fragment and recloned into the Klenow-blunted HindIII site of pMTL24 (7) to form pMCm. This plasmid contains the CAT coding region flanked on both sides with several identical restriction enzyme sites (see Fig. 4 ). An oligonucleotide site-directed mutation in algL was constructed with the polymerase chain reaction (PCR) method of Mikaelian and Sergeant (41) (see text for details).
DNA sequencing. A series of overlapping deletions of the ca. 1.9-kb insert fragment of clone pSM1-5 (Table 1) were prepared with the Erase-a-Base System (Promega Corporation, Madison, Wis.). Clone pSMl-5 with the gene in the same orientation as the vector promoter was employed for sequential exonuclease III deletions progressing from the left side of the insert as shown in Fig. 2 . To sequence the other DNA strand, the 1.9-kb EcoRI insert fragment in pSMl-5 was recloned into the same site of pUC128 but in the opposite orientation. The orientation in which the algL gene was anti to the vector promoter (pSM2-14) was selected for construction of exonuclease III deletions that were then used for sequencing. Some of these deletions were also recloned into pUC129 as HindIII-EcoRI fragments and tested for their alginate lyase activity in E. coli cells on YC alginate plates (see below). In some cases, internal restriction fragments were subcloned in pUC129 and were endsequenced. (12) .
Nucleotide sequence accession number. The nucleotide sequence of algL shown in Fig. 3 (9) . Restriction mapping studies were used to identify the location of these insertions (Fig. 1) . As shown in Table 2 (which we designated algL) was located at or near the TnS01-28 insertion site (Fig. 1) .
To ensure that the alginate Iyase-negative phenotype of the alg::TnSOJ mutants resulted from the TnS01 insertions and was. not due to spontaneous nonmucoid conversion at algT (46) or to mutations at other regulatory loci (e.g., algB or algRPQ; see reference 40), the complete alginate gene cluster was reconstructed in the chromosome of the alg::TnSOJ mutants. pALG2 (Fig. 1) , which contains the entire alginate gene cluster, was conjugally transferred to P. aeruginosa by triparental mating and selection for carbenicillin resistance. The integration of pALG2 into the chromosome of the FRD1::TnSOJ derivatives occurred at a single cross-over by homologous recombination because this plasmid has a narrow host range (9) . This resulted in a complete functional alginate gene cluster, and colonies displayed the mucoid phenotype. Complementation of the TnSOJ-mutagenized genes with pALG2 confirmed that the TnSOI insertions within the designated areas shown in Fig. 1 were responsible for blocking mucoidy and alginate lyase expression.
Expression of the algL gene in E. coli. Genetic manipulations of the algL region of the alginate gene cluster were performed to determine the location of algL and whether it encodes alginate lyase. A 3.4-kb EcoRI fragment from pCC27, which should include the algL region (Fig. 1) , was cloned into the EcoRI site of expression vector pKK223-3 to generate pNLS1. Ampicillin-resistant transformants of E. coli JM109 were screened for the presence of the 3.4-kb EcoRI fragment in both orientations behind the resident tac promoter in the vector. These strains, as well as the vectortransformed control, were grown to early log phase, and the tac promoter was induced with 1 mM IPTG. Growth was allowed to continue for an additional 4 h at 37°C. The bacteria were harvested, crude enzyme extracts were prepared, and alginate lyase activity was measured and compared with that in FRD1. As shown in Table 3 , there was no alginate lyase activity in E. coli JM109 (pKK223-3), but activity was demonstrated in JM109 (pNLS1), which carried the 3.4-kb EcoRI fragment in the orientation shown in Fig. 1 . Constructs which carried this same insert in the opposite orientation did not express enzymatic activity (extracts were examined with the thiobarbituric acid assay). These results showed that the algL gene encodes an alginate lyase and that it is oriented in the same direction as other alginate biosynthetic genes in the cluster (Fig. 1) . The location of TnS01-14 just beyond the apparent alginate lyase coding region provided a convenient transposon EcoRI site just downstream of the two XhoI sites (see the top of Fig. 2) , which was exploited for further subcloning. The resultant ca. 1.9-kb EcoRI DNA fragment from pCC27::
TnS01-14 was therefore isolated and cloned into pUC128 in both orientations. Strong alginate lyase activity, as determined by depressions on YC alginate plates, was observed when this fragment was oriented with the XhoI sites positioned furthest downstream of the lac promoter in pUC128 (pSM1-5), but weak enzymatic activity was also detected when the insert was in the opposite orientation (pSM2-14). This 1.9-kb EcoRI insert was also cloned in both orientations in pBluescript II KS'. When the transcribing orientation was downstream of the lac promoter (pNLSll; Table 1 ), high levels of alginate lyase activity in E. coli cells were observed on YC alginate plates, while the opposite orientation (pNLS10) expressed low levels of activity.
Sequencing the algL gene. The 1.9-kb EcoRI fragment encoding the alginate lyase gene was sequenced. Since only one orientation of this fragment relative to the lac promoter in pUC plasmids resulted in high levels of alginate lyase production in E. coli cells, it was assumed that the reading frame occurred on the DNA strand shown in Fig. 3 . The DNA sequence data (Fig. 3) showed the occurrence on this DNA strand of two overlapping, long open reading frames (ORFs). On the basis of the information described below, the smaller one of these, ORF1, appeared to encode the alginate lyase activity, and is therefore termed algL. ORFi initiated with the ATG at base 463 and terminated with a TGA codon at base 1564. Location of the termination codon at this position was supported by exonuclease III deletion A2B at base 1679, which was fully active in the YC alginate lyase plate test, and by deletion A1OA at position 1471, which was devoid of detectable activity (Fig. 2) . A plasmid construct (pNLS12) in which the ca. 300-bp XhoI fragment (Fig. 3) was deleted was also alginate lyase negative, as predicted from placement of the translational stop codon. The translational start codon was located between deletion A2.7 at base 368, which was fully alginate lyase positive, and deletion A4.1 at base 539, which was devoid of activity (Fig. 2) . The only ATG start codon between these deletions which was correctly located relative to a Shine-Dalgarno box occurred at base 463. An ATG codon in the same reading frame at base 379 was followed by a translational termination codon at base 457. A contiguous reading frame extends from position 1 of the sequenced region to the TAA codon at position 457.
This could represent the 3' end of another ORF which occurs immediately upstream of algL, but data concerning this possibility are not yet available.
The algL ORF shown in Fig. 3 leader peptide (60) . Thus, several basic and polar amino acids occurred in the first eight amino acids, followed by a string of 13 hydrophobic residues and then six C-region amino acids, several of which are polar. The putative signal peptide sequence was predicted to cleave between two alanine residues, amino acids 27 and 28 (Fig. 3) . This was confirmed by N-terminal amino acid sequencing data, which are discussed in more detail later. The resulting mature secreted protein thus contained 340 amino acids with a predicted molecular weight of 38,112. The ORF encompassing the pre-protein was 68% G+C overall and 92% G+C in the third coding position. Three NotI restriction sites occurred in the sequenced region as well as several sites for other G+C-rich restriction enzymes. Such a high G+C content is similar to those of other P. aeruginosa genes, including another member of the alg operon, algE (10 (Fig. 4) that had been partially restricted with KpnI and transformed into E.
coli. The resulting E. coli transformants were screened to select a plasmid (pNLS14) in which the CAT cartridge was inserted into the unique KpnI site of the algL gene (Fig. 4) .
As predicted, this construct was devoid of alginate lyase activity in E. coli cells, further supporting the identity of ORFi as algL, the alginate lyase gene.
A mutation was constructed in which the putative start (ATG) and second (AAA) codons of algL were altered by mutation in order to confirm their role in the coding sequence. This was done by the PCR method of Mikaelian and Sergeant (41) in which the ca. 600-bp KpnI fragment of pSM1-5 was amplified in the presence of the oligonucleotide 5'GGGAGGTAAACGAAHTCAACGTCCCAC3' (where altered codons 1 and 2 are underlined). The PCR-amplified product from the ORF KpnI site to the ATG removed at position 463 was sequenced and confirmed to be correct. The PCR products were cloned into pUC128, transformed into E. coli DH5ao, and the resultant plasmids were screened for an EcoRI site (GAATTC) introduced by the mutagenesis at position 462 (Fig. 3) . One such plasmid was retained, and the DNA sequence of the mutated algL gene was confirmed by sequence analysis. The ca. 600-bp KpnI fragment was then recloned in the correct orientation into the wild-type algL gene of pNLS11. This construct, called pNLS15, was transformed into E. coli cells.
When expressed in E. coli JM109 or JA-221, pNLS15 demonstrated little or no alginate lyase activity on YC alginate plates, further supporting the prediction that the methionine residue at position 463 is the translational initiation site of algL. This was further confirmed when the ca. 1.5-kb EcoRI insert fragment from pNLS15 was cloned into pUC129 to generate pNLS16. This should result in a translational fusion of algL with the lacZa fragment of pUC129. When transformed into E. coli JA-221, a high level of alginate lyase activity was observed on YC alginate plates. These data confirm the occurrence of the ATG at base 463 as the translational start of algL.
Expression of alginate Iyase activity. Several E. coli strains were evaluated for their ability to maintain algL plasmid constructs and express alginate lyase activity. Strain DH5a did not maintain several of the high-expression constructs well, exhibiting growth inhibition on Luria-ampicillin medium and alteration of the plasmids associated with loss of alginate lyase activity. Strain JM109 suitably maintained most of the plasmid constructs when grown on Luriaampicillin plates but did not produce as high levels of activity of alginate lyase as strains MC1061 or JA-221. Plasmids leading to high levels of alginate lyase activity were also not maintained well in strain MC1061 but were retained through several single colony transfers in strain JA-221 on Luriaampicillin plates supplemented with 0.3% glucose. Despite the fact that strain JA-221 has an episomal lac 1q gene which should aid in repressing vector lac promoters in the absence of IPTG induction, the addition of glucose was necessary to further repress the vector promoter. Strain JA-221 therefore appeared to be the best expression host of those screened for the algL gene.
SDS gel electrophoresis of whole E. coli JA-221 cells showed the presence of a ca. 39-kDa band that was unique to algL plasmid constructs exhibiting strong alginate lyase activity on YC alginate plates. As shown in Fig. 5 An SDS-polyacrylamide gel of whole E. coli JA-221 cells containing pNLS17 was electroblotted onto a polyvinylidene fluoride membrane, the 39-kDa protein band was excised, and its N-terminal amino acid sequence was determined by the University of California, Riverside, Biotechnology Instrumentation Facility. The N-terminal amino acid sequence (16 amino acids) exactly matched that predicted from the nucleotide sequence shown in Fig. 3 , starting with the Ala-28 residue, confirming the predicted location of the cleavage of the signal peptide sequence (Fig. 3) .
DISCUSSION
These results demonstrate that the alginate lyase structural gene (algL) is located within the alginate biosynthetic gene cluster between algG and algA at 35 min on the P. aeruginosa chromosome. This location had been predicted by the observations that alginate lyase production was controlled by AlgB, which also regulates the alginate biosynthetic gene cluster (63) , and was stimulated by high salt concentrations (50) , which also upregulate alginate biosynthesis (4). The results of our genetic manipulations in P. aeruginosa are also consistent with recent studies which show that genes in the alginate cluster may be organized as an operon (9) . Strong alginate lyase activity was detected when the algL gene was inserted behind vector promoters in the orientation shown in Fig. 1 , consistent with the orientation of known biosynthetic genes in the operon. However, low but clearly detectable levels of activity were observed when the gene was oriented in the opposite direction (noted with YC alginate plates). This suggests the possibility of a weak internal promoter for algL. Chu et al. (10) also detected a weak internal promoter for algE, a gene which is found upstream of algL but downstream of algD and within the biosynthetic operon-like structure. The importance of an internal promoter for algL in the in vivo regulation of this enzyme needs further study.
The observation that the P. aeruginosa FRD1 alginate lyase enzyme produced in E. coli was approximately 39 kDa is comparable to the size of the semi-purified P. aeruginosa enzyme from strain WcM#2 (50) . The inferred amino acid sequence derived from our DNA sequence analysis of algL showed a potential signal sequence for AlgL. Periplasmic localization of the lyase is consistent with the procedures required to release the enzyme from both P. aeruginosa and E. coli strains and is an area currently under investigation.
Expression of the cloned algL gene in E. coli not only verified the location of the structural gene for alginate lyase but also provided a source of the enzyme which can be used for protein purification and characterization studies. Other investigators have recently cloned alginate lyases from other species, including a guluronidase from Kebsiella pneumoniae (6) and a mannuronidase from a marine bacterium (5) . Similarities between AlgL and the sequences of these enzymes, once they are reported, may provide information on the structure-function relationships of the P. aeruginosa alginate lyase.
The occurrence of algL within the biosynthetic operon suggests that the enzyme it encodes might have a role in alginate biosynthesis. Certainly, the production of this alginate lyase does not prohibit alginate polymer formation. However, the mucoid phenotype of a nonpolar mutation in algL, which does not block algA expression, should reveal whether AlgL is necessary or somewhat inhibitory to maximal polymer formation. Localization of algL within the biosynthetic cluster may actually facilitate regulation of the system in vivo, a model proposed by Romeo et al. (48) to explain the presence of catabolic genes within the glycogen biosynthetic cluster in E. coli. Alternatively, AlgL, which is functionally a depolymerase in vitro, may function in vivo as a component of an alginate polymerization reaction complex.
Characterization of P. aeruginosa algL may also have practical applications. The inability of current therapeutic strategies to clear mucoid P. aeruginosa strains from the lungs of CF patients has stimulated interest in developing novel strategies for eradicating the bacteria from patients. One possibility is to use a combination of alginate-degrading enzymes and conventional antibiotic therapy. Previous studies have shown that alginate lyase treatment of mucoid P. aeruginosa can render these bacteria more susceptible to nonopsonic phagocytosis and antibiotics both in vitro (3, 21) and in vivo (2) . Studies are in progress to determine whether alginate lyase can reduce the viscosity of some CF sputum samples and in this capacity also provide an additive effect to DNase (51) 
